Showing results (211-220 of 244) with videos related to
Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|June 1, 1974
Susceptibility of Clostridium ramosum to antimicrobial agentsF P Tally, A Y Armfield, V R Dowell, et al.Antimicrobial Agents and Chemotherapy|October 19, 2000
Once-daily dosing in dogs optimizes daptomycin safetyF B Oleson, C L Berman, J B Kirkpatrick, et al.Antimicrobial Agents and Chemotherapy|February 1, 1975
Effect of diuretics on urinary excretion of cephalothin in humansA D Tice, M Barza, M G Bergeron, et al.Proceedings of the National Academy of Sciences of the United States of America|March 1, 1988
A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infectionJ W van der Meer, M Barza, S M Wolff, et al.Antimicrobial Agents and Chemotherapy|August 1, 1994
Mechanistic studies and biological activity of bioxalomycin alpha 2, a novel antibiotic produced by Streptomyces viridodiastaticus subsp. "litoralis" LL-31F508M P Singh, P J Petersen, N V Jacobus, et al.Antimicrobial Agents and Chemotherapy|February 27, 1999
In vitro activities of aminomethyl-substituted analogs of novel tetrahydrofuranyl carbapenemsW J Weiss, P J Petersen, N V Jacobus, et al.European Journal of Immunology|July 1, 1988
Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1J W Van't Wout, J W Van der Meer, M Barza, et al.BMJ (Clinical Research Ed.)|September 4, 1998
Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysisS D de Ferranti, J P Ioannidis, J Lau, et al.Expert Opinion on Investigational Drugs|July 5, 2005
Daptomycin: a novel agent for Gram-positive infectionsF P Tally, M Zeckel, M M Wasilewski, et al.Antimicrobial Agents and Chemotherapy|September 1, 1978
Penetration of clindamycin into decubitus ulcersS A Berger, M Barza, J Haher, et al.Pageof 25